ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

Barbara Rimer and Owen Witte To Be Named Members Of the President’s Cancer Panel

December 9, 2011

NRC Undertake Diet, Nutrition And Cancer , Plans Meeting Nov. 6

September 26, 1980

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006

GM Foundation Awards Prizes

June 13, 2003

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995